Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study

Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study

Song Zhang, Xin Wang, Hao Gu, Jun-Qi Liu Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People’s Republic of ChinaCorrespondence: Jun-Qi Liu, Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, N...

Full description

Bibliographic Details
Main Authors: Zhang S, Wang X, Gu H, Liu JQ
Format: Article
Language:English
Published: Dove Medical Press 2022-05-01
Series:Cancer Management and Research
Subjects:
esophageal squamous cell carcinoma
anlotinib
efficacy
safety
hypertension
biomarker
Online Access:https://www.dovepress.com/feasibility-and-safety-of-anlotinib-monotherapy-for-patients-with-prev-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/feasibility-and-safety-of-anlotinib-monotherapy-for-patients-with-prev-peer-reviewed-fulltext-article-CMAR

Similar Items